Objective: To evaluate clinical and laboratory profiles of patients with type 1 diabetes mellitus in three public hospitals in São Paulo, Brazil, since type 1 diabetes mellitus is a chronic illness that occurs mainly in the pediatric age group in the Brazilian population.
Introduction
Type 1 diabetes mellitus (T1DM) is one of the most serious endocrine diseases of childhood and adolescence.
Its incidence, which varies between countries and different ethnic groups, ranges from 0.1 to 37.4/100,000 among children 0 to 14 years. 1 The purpose of diabetes treatment is to achieve metabolic balance and to ensure patient well being.
Evidence shows that improved blood glucose control reduces the risk of chronic complications and is associated with better quality of life. 2 Intensive insulin regimens have been suggested, but their use alone does not ensure that expected optimal blood glucose control is achieved. Factors such as diabetes education, support of healthcare team, self-monitoring, and patient's satisfaction may be more importantly associated with improved disease control than intensive treatment. 3 The recommendations made in the Diabetes Control and Complications Trial (DCCT) demand important changes in patient's behavior: self-monitoring of capillary blood glucose three to four times a day, four daily insulin injections or use of an insulin pump, changes in eating habits, practice of planned physical activities, and adjustment of insulin doses according to dietary intake and exercise. 4 The DCCT demonstrated that intensive treatment of 13-to 39-year-old patients delays the onset and progression of retinopathy, nephropathy and diabetic neuropathy, and that there is an association between blood glucose levels, glycosylated hemoglobin (HbA 1c ) and microvascular complications in patients with diabetes. 4 Hypoglycemia is a limiting factor to intensive glycemic control, especially in small children who are under risk of cognitive alteration after repetitive hypoglycemic episodes. 5 Although the risk of hypoglycemia was greater in patients undergoing intensive therapy, benefits outweighed the risk of hypoglycemia [6] [7] [8] and now the basal-bolus regimen with rapid-acting analogs (aspart, lispro) given in bolus generally reduce hypoglycemia episodes and postprandial glycemia levels, while basal insulin analogs (detemir, glargina) tend to reduce particularly the number of episodes of nocturnal hypoglycemia. 5 Intensive diabetes treatment is based on the adaptation of insulin regimens to the results of blood glucose selfmonitoring, and should not be determined only by the number of daily insulin injections. 9 Strict clinical and laboratory control and individualized treatment should be determined by a multidisciplinary team. Moreover, patients and their families should receive education about the treatment and be prepared to adhere to it. This study, which was conducted to improve patient follow-up, evaluated the clinical and laboratory profiles of children and adolescents with T1DM in three public hospitals that are excellence centers for patients with T1DM in the state of São Paulo, Brazil.
Patients and methods
This cross-sectional study was conducted in the middle of 
Discussion
In recent years, the concept of metabolic control has gained importance in the analysis of onset and progression of chronic complications of diabetes, and the concept of dissociation between metabolic control and onset of these complications was left behind in the history of diabetology.
The DCCT concluded that there is a reduction of about 60% in the risk of retinopathy, nephropathy and diabetic neuropathies in patients with good control. 4 Recent studies also found a reduction of 42% in cardiovascular risk in patients that undergo intensive treatment for diabetes mellitus. 10 Moreover, each 1% reduction in the levels of More than only type of insulin, number of insulin shots or finger glucose dosages seem to be important. The team approach, frequent educational meetings and also psychological issues are very important, mainly in the adolescent group. 12, 14, 15 A great number of patients (32.6%) used premixed insulins, which have already been reported to be associated with poor metabolic control in adolescents. 11 However, mean HbA 1c in this group of patients was similar to that of patients that used only NPH or NPH and regular insulin.
The group with the lowest mean HbA 1c was that of patients that used NPH and lispro insulin, which may be explained by lispro's greater efficacy in rapidly reducing postprandial glucose levels.
The same results were found in other studies. Use of NPH insulin with rapid analogues in the same shot reduces HbA 1c by reducing postprandial glucose levels. The best way to control T1DM patients is the basal/bolus approach, which was not being used in this study group. 16, 17 Most patients (74.9%) had two daily insulin injections and those that had three injections had greater mean HbA 1c . This is the group of patients in whom the disease duration was longer. We could speculate that as those patients were the oldest (adolescents), metabolic control was decreased by poor adherence to the treatment, as reported by other authors. 15 
Conclusion
Although this study was conducted with patients followed up in reference hospitals of three cities in one of the most developed Brazilian state, optimal blood glucose control, evaluated according to level of HbA 1c , was not achieved when only the number of daily insulin injections or the daily insulin dose was increased. The data showed that multidisciplinary teams still face great challenges to prescribe individualized treatments that respond to the needs of each patient with T1DM, and suggest that education should be the basis of successful treatments.
We also believe that new approaches, such as multiple insulin doses, insulin pumps and carbohydrates counting, could be helpful in improving metabolic control. Economic and social issues must be confronted, a major challenge for coming years.
